Pfizer
sues generic drug makers
08 February, 2006
Pfizer Inc. has filed a patent infringement
suit against generic
drug makers Teva Pharmaceutical Industries Ltd.
and Sandoz Inc. concerning generic versions of the antibiotic
Zithromax. Representatives from Sandoz, based in Princeton,
N.J., and Teva, based in Israel, couldn't immediately
be reached for comment.
In a press release Wednesday, Pfizer also said it filed
a petition with the U.S. Food and Drug Administration,
claiming Teva's and Sandoz's azithromycin product labels
do not accurately describe the drug's active ingredients.
According to Pfizer, the generics contain significant
amounts of azithromycin sesquihydrate, rather than the
azithromycin monohydrate that their labels state.
Generic drugs are an affordable means of availing treatment.
Erectile dysfunction
generic pills have provided relief to millions of its
users worldwide.
To read more, Visit:
http://seattlepi.nwsource.com/business/1310AP_Pfizer_Teva_Suit.html
|